about
Potentiation of placebo analgesia by proglumideResponse variability to analgesics: a role for non-specific activation of endogenous opioids.Shared "core" areas between the pain and other task-related networksThe magnitude of nocebo effects in pain: a meta-analysis.The specific effects of prior opioid exposure on placebo analgesia and placebo respiratory depression.The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect.Do we need a new procedure for the assessment of adverse events in anti-migraine clinical trials?The placebo response: how words and rituals change the patient's brain.A systematic review of adverse events in the placebo arm of donepezil trials: the role of cognitive impairment.Mechanisms of the placebo response.Nocebo vs. placebo: the challenges of trial design in analgesia research.Metaphor comprehension in Alzheimer's disease: novelty matters.Experimental pain processing in individuals with cognitive impairment: current state of the science.Lessons Learned From Nocebo Effects in Clinical Trials for Pain Conditions and Neurodegenerative Disorders.A novel framework for understanding reduced awareness of dyskinesias in Parkinson's Disease.The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin.Response expectancies in placebo analgesia and their clinical relevance.Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors.Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems.Inducing placebo respiratory depressant responses in humans via opioid receptors.Somatotopic activation of opioid systems by target-directed expectations of analgesia.Impaired awareness of deficits in Alzheimer's disease: the role of everyday executive dysfunction.Neuropsychological Correlates of Pre-Frailty in Neurocognitive Disorders: A Possible Role for Metacognitive Dysfunction and Mood Changes.Neural correlates of reduced awareness in instrumental activities of daily living in frontotemporal dementia.Pain anticipation: an activation likelihood estimation meta-analysis of brain imaging studies.Impaired awareness of movement disorders in Parkinson's disease.Self-unawareness of levodopa induced dyskinesias in patients with Parkinson's disease.Quantitative EEG responses to ischaemic arm stress in migraine.Unawareness of deficits in ischemic injury: role of the cingulate cortex.Nocebo effects and psychotropic drug action.Unawareness of deficits in Alzheimer's disease: role of the cingulate cortex.Corrigendum to "Neural correlates of reduced awareness in instrumental activities of daily living in frontotemporal dementia" [Exp. Gerontol. 83 (2016) 158-164].Activation likelihood estimation meta-analysis of brain correlates of placebo analgesia in human experimental painUnawareness of bipolar disorder: the role of the cingulate cortexNonopioid placebo analgesia is mediated by CB1 cannabinoid receptorsDose-response relationship of opioids in nociceptive and neuropathic postoperative painNeurophysiologic assessment of nerve impairment in posterolateral and muscle-sparing thoracotomyPostthoracoscopy pain: is TENS the answer?Postoperative Pain and Superficial Abdominal Reflexes After Posterolateral ThoracotomyAre Patients With Schizophrenia Spectrum Disorders More Prone to Manifest Nocebo-Like-Effects? A Meta-Analysis of Adverse Events in Placebo Groups of Double-Blind Antipsychotic Trials.
P50
Q28283820-07DDFD26-4E36-4BC1-821A-59A82CAF4E16Q32025386-7B05DDE5-EDA2-4155-BE59-76E401F7976EQ34382364-85458C8E-0159-497F-991D-7DA86A5252B5Q34421462-794D7171-DED6-498B-86B9-9DA6612FA7FBQ34467793-6692A165-FCF3-4A30-954F-56CFA15B6825Q34581978-133BBCDF-B98E-4320-9ACB-4377B2A7096EQ37813732-184CC7B0-FC24-432D-8194-FEA57F56D253Q37881388-AE5BC3D7-E58D-4B58-B911-84186F24530BQ37973138-2C645F78-EAD8-4C41-BD73-63B976551B96Q38078181-15808E94-F48C-4C0E-B978-071316C1CF26Q38351533-FE30ADA1-8632-4FD2-8B67-101E07F82828Q38394839-F0A1D058-81C2-4EFF-9658-7226A85CF9C6Q38548382-C8DD32F4-C48B-4DAF-AAF0-58C2153D843FQ38825910-D9FC17DC-D492-4C35-957F-F862F1A559DEQ40281998-2E4164AD-558B-4837-81A9-2C4F8ABD754BQ41499548-93B221B7-F82E-40E4-AB1A-8DF62E8B5416Q43640195-3F8C74F3-82D0-4FAD-8548-E9204DE541F5Q44348000-4C4F530E-AA61-468F-ADFE-FD8E7E259B54Q44350969-A677438A-EB49-4F85-86C1-55252F55617AQ44351413-5CCF8841-FEC0-4036-87D4-82D12241B6A7Q44351840-CB4A3965-05DC-4A11-9807-65C7CCA0F1A4Q45407280-D93A85E7-E284-4194-BBD1-F8A213C76687Q47116744-FAC93377-0FCD-497A-9379-65BF1F46F8CAQ47958298-191D4E4A-CF66-44FC-81A8-596E804AB0CAQ48404113-8B097256-0187-475F-B645-BAFAE15078BDQ48407147-7E5570C3-A748-4F7E-AA7B-C45384FDA32AQ48639592-CC33B176-184D-4CD1-80DA-32D5364152C6Q48820249-7826CEFC-975E-4BC1-BB8C-FA378BA22536Q49136909-D12A24FA-B5AB-4493-8BCD-5F06150BA219Q50616272-6C82F47C-ED69-4B07-8520-B59E952D505CQ51017551-0747B1E6-72DC-421D-8552-0FDC3FDBB1F7Q53505749-0CAD6C46-644A-44AC-8459-86C48DA1FEF7Q60683620-A4108FDB-7DB2-4378-A3CD-29EA8F196647Q60688265-C31BDA65-3CB7-4323-A0A7-8CF52AD7D350Q60688268-C2C0AA66-129A-4159-9467-A9A0F5452293Q60688278-A946D7AE-1D97-401E-B343-A8481926CB9FQ60688305-F929F473-4419-43C1-8D6A-C863D7F82390Q60688311-C4395B31-3641-47F3-957D-01C17F5149E8Q60688314-29082C91-D35E-4582-822E-E8C185B906CCQ64963575-F63375FE-9A85-4AAA-BA35-F44B5CB8F6FF
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Martina Amanzio
@ast
Martina Amanzio
@en
Martina Amanzio
@es
Martina Amanzio
@nl
Martina Amanzio
@sl
type
label
Martina Amanzio
@ast
Martina Amanzio
@en
Martina Amanzio
@es
Martina Amanzio
@nl
Martina Amanzio
@sl
prefLabel
Martina Amanzio
@ast
Martina Amanzio
@en
Martina Amanzio
@es
Martina Amanzio
@nl
Martina Amanzio
@sl
P1053
A-9085-2010
P106
P21
P31
P3829
P496
0000-0002-2504-032X